Board Appointment

RNS Number : 2637P

Dechra Pharmaceuticals PLC

23 October 2012

 



Date: Tuesday 23 October 2012

Dechra^® Pharmaceuticals PLC

("Dechra" or "the Company") 

Director Declaration

Director Appointment:

On 19 October 2012, the Company announced the appointment of Tony Griffin as an Executive Director, effective from 1 November 2012. Tony, who was previously CEO of Eurovet Animal Health B.V. ("Eurovet") and AUV Holding B.V ("AUV") (together, "AUV Group"), joined Dechra as Managing Director of Dechra Veterinary Products Europe following the acquisition of Eurovet by Dechra from the AUV Group in May 2012. He brings with him a wealth of market knowledge and management skills that will further strengthen Dechra's Executive team.

We hereby confirm that there are no matters which require to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules.

Tony Griffin's beneficial holding in the Company is 12,077 shares, which represents 0.014% of the issued share capital.

Zoe Goulding

Company Secretary

23 October 2012

 

END

 

 

BOAFEMFWEFESESS